A 'Fountain Of Youth' Pill? Sure, If You're A Mouse.
news article · 2019
LINK
SUMMARY
KFF Health News investigation into the gap between mouse longevity research and marketed anti-aging supplements, centered on David Sinclair. Reports that Sinclair described resveratrol to the journal Science as 'as close to a miraculous molecule as you can find'; that he is involved as a founder, investor, equity holder, consultant, or board member with 28 companies, at least 18 anti-aging-related; that he is listed as an inventor on a NAD-booster patent licensed to Elysium Health (which sells a $60 NAD-booster pill); and that he is an investor in InsideTracker, a company whose tests he has cited for his own biological-age claims. Byline, date, and publisher confirmed directly on the fetched page.
NOTES
The case’s primary financial-conflict source: an independent journalistic accounting, published by a nonprofit health-policy newsroom, of the scale and structure of Sinclair’s commercial interests in the science he promotes.